Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v7-FR
Language French French
Date Updated 2019-04-03 2019-01-15
Drug Identification Number 02275104 02275104
Brand name WELLBUTRIN XL WELLBUTRIN XL
Common or Proper name WELLBUTRIN XL WELLBUTRIN XL
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C. VALEANT CANADA LP/VALEANT CANADA S.E.C.
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 300MG 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 90's 90's
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-01-28
Actual start date 2019-02-03
Estimated end date 2019-02-11
Actual end date 2019-04-02
Shortage status Resolved Anticipated shortage
Company comments Allocating inventory to support regular demand. Allocating inventory to support regular demand.
Health Canada comments